| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| GLAUKOS Corp | Director | Common Stock | 21.7K | $1.89M | $86.86 | May 29, 2025 | Direct |
| 2seventy bio, Inc. | Director | Stock Options (Right to buy) | 24.1K | $94.7K | $3.93 | Jun 10, 2024 | Direct |
| GLAUKOS Corp | Director | Stock Option (Right to Buy) | 3.15K | $86.3K | $69.30 | May 29, 2025 | Direct |
| bluebird bio, Inc. | Director | Common Stock | 2.73K | $3.9K | $1.43 | Nov 11, 2021 | Direct |
| 2seventy bio, Inc. | Director | Common Stock | 0 | $0 | $4.94 | May 13, 2025 | Direct |
| Karuna Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $330.00 | Mar 18, 2024 | Direct |
| Karuna Therapeutics, Inc. | Director | Option (right to buy) | 0 | $0 | $92.30 | Mar 18, 2024 | Direct |
| Celldex Therapeutics, Inc. | Director | Non-Qualified Stock Option (right to buy) | 33K | Jun 5, 2025 | Direct | ||
| Surface Oncology, Inc. | Director | Stock Option (Right to Buy) | 24K | Jun 8, 2022 | Direct | ||
| 2seventy bio, Inc. | Director | Stock Options (Right to buy) | 0 | May 13, 2025 | Direct | ||
| bluebird bio, Inc. | Director | Stock Option (right to buy) | 0 | Nov 11, 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CLDX | Celldex Therapeutics, Inc. | Jun 5, 2025 | 1 | $0 | 4 | Jun 9, 2025 | Director |
| CLDX | Celldex Therapeutics, Inc. | Jun 5, 2025 | 0 | $0 | 3 | Jun 6, 2025 | Director |
| TSVT | 2seventy bio, Inc. | May 13, 2025 | 3 | $0 | 4 | May 15, 2025 | Director |
| GKOS | GLAUKOS Corp | Jan 2, 2025 | 3 | $0 | 4 | Jun 2, 2025 | Director |
| TSVT | 2seventy bio, Inc. | Jun 10, 2024 | 2 | $0 | 4 | Jun 12, 2024 | Director |
| GKOS | GLAUKOS Corp | May 30, 2024 | 2 | $0 | 4 | Jun 3, 2024 | Director |
| KRTX | Karuna Therapeutics, Inc. | Mar 18, 2024 | 5 | -$9M | 4 | Mar 18, 2024 | Director |
| GKOS | GLAUKOS Corp | Jan 2, 2024 | 1 | $0 | 4 | Jan 4, 2024 | Director |
| KRTX | Karuna Therapeutics, Inc. | Jun 20, 2023 | 2 | $0 | 4 | Jun 22, 2023 | Director |
| TSVT | 2seventy bio, Inc. | Jun 13, 2023 | 2 | $0 | 4 | Jun 15, 2023 | Director |
| GKOS | GLAUKOS Corp | Jun 1, 2023 | 1 | $0 | 4 | Jun 5, 2023 | Director |
| GKOS | GLAUKOS Corp | Jan 3, 2023 | 1 | $0 | 4 | Jan 4, 2023 | Director |
| KRTX | Karuna Therapeutics, Inc. | Jun 15, 2022 | 1 | $0 | 4 | Jun 16, 2022 | Director |
| SURF | Surface Oncology, Inc. | Jun 8, 2022 | 1 | $0 | 4 | Jun 10, 2022 | Director |
| TSVT | 2seventy bio, Inc. | Jun 8, 2022 | 2 | $0 | 4 | Jun 9, 2022 | Director |
| GKOS | GLAUKOS Corp | Jun 2, 2022 | 1 | $0 | 4 | Jun 6, 2022 | Director |
| GKOS | GLAUKOS Corp | Jan 3, 2022 | 1 | $0 | 4 | Jan 5, 2022 | Director |
| SURF | Surface Oncology, Inc. | Jan 3, 2022 | 1 | $0 | 4 | Jan 5, 2022 | Director |
| BLUE | bluebird bio, Inc. | Nov 11, 2021 | 4 | $0 | 4 | Nov 17, 2021 | Director |
| TSVT | 2seventy bio, Inc. | Nov 11, 2021 | 4 | $0 | 4 | Nov 16, 2021 | Director |
| TSVT | 2seventy bio, Inc. | Oct 18, 2021 | 0 | $0 | 3 | Oct 18, 2021 | Director |
| SURF | Surface Oncology, Inc. | Aug 2, 2021 | 1 | $0 | 4 | Aug 3, 2021 | Director |
| SURF | Surface Oncology, Inc. | Jul 6, 2021 | 0 | $0 | 3 | Jul 8, 2021 | Director |
| KRTX | Karuna Therapeutics, Inc. | Jun 16, 2021 | 1 | $0 | 4 | Jun 23, 2021 | Director |
| BLUE | bluebird bio, Inc. | Jun 15, 2021 | 2 | $0 | 4 | Jun 17, 2021 | Director |
| GKOS | GLAUKOS Corp | Jun 3, 2021 | 1 | $0 | 4 | Jun 7, 2021 | Director |